Takeda Pharmaceuticals U.S.A., Inc.
$199.9M 172,058 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Medtronic, Inc.
Medtronic, Inc. reported $189,918,595.39 across General Payments, Research, and Ownership to 342,681 physicians and teaching hospitals across 353,343 transactions.
- $189.9M Top 1% payer
- All-tracks total
- 353,343 Top 1% volume
- Transactions
- 342,681 Top 1% reach
- Recipients
- −$20.3K
- General Payments vs PY2023
Medtronic, Inc. reported $189,918,595.39 across all CMS Open Payments tracks (General + Research + Ownership) to 342,681 physicians and teaching hospitals in Program Year 2024 - ranking #16 of 1,925 reporting manufacturers (1.4% of the all-tracks industry total); General Payments alone were $117,697,731.43, averaging $554.21 per recipient.
How Medtronic, Inc.'s $189.9M all-tracks total breaks down
Medtronic, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
100/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer medtronic-inc Medtronic, Inc.
$189.9M · #16/1,925 · 1.4% industry · PY2024
- TOT $189.9M
- RANK #16
- SHARE 1.4%
- TXN 353,343
- RCP 342,681
- CAT 14
- GEN $117.7M
- ΔGEN −$20.3K
- TOP1 14.0%
- PY 2024
Volume peers
Nearest volume peer: Takeda Pharmaceuticals U.S.A., Inc. ($199.9M)
Medtronic, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Medtronic, Inc.'s CMS-reported General Payments decreased by $20.3K (−0.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MEDTRONIC, INC.PY2023: MEDTRONIC, INC.PY2024: Medtronic, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $117,718,051.86
- PY2024
- $117,697,731.43
What the Data Shows for Medtronic, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Medtronic, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
573 transactions worth $46.8M make "Royalty or License" the top general-payment category in the 14-category breakdown below, 39.7% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Royalty or License" leads Medtronic, Inc.'s 14-category general-payment breakdown at $46.8M, 39.7% of the reported total.
Medtronic, Inc. reports 14 general-payment categories - the top three are Royalty or License (39.7%), Compensation for Services Other Than Consulting (18.6%), and Food and Beverage (11.1%). The remaining 11 categories make up 30.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Medtronic, Inc. files across 14 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Medtronic, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $46.8M | 573 | 39.7% |
| Compensation for Services Other Than Consulting | $21.8M | 6,775 | 18.6% |
| Food and Beverage | $13.0M | 278,487 | 11.1% |
| Travel and Lodging | $11.6M | 50,441 | 9.8% |
| Consulting Fee | $8.2M | 2,756 | 7.0% |
| Acquisitions | $6.9M | 49 | 5.9% |
| Grant | $6.8M | 792 | 5.8% |
| Space Rental or Facility Fees | $1.8M | 167 | 1.5% |
| Debt Forgiveness | $312.3K | 39 | 0.3% |
| Long-Term Medical Supply or Device Loan | $239.8K | 37 | 0.2% |
| Education | $233.7K | 2,524 | 0.2% |
| Compensation for Faculty or Speaker (Medical Education) | $58.9K | 34 | 0.1% |
| Charitable Contribution | $15.3K | 4 | 0.0% |
| Gift | $124.63 | 3 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $29,618,842.49 (25.2%) of $117,697,731.43 in this company's General Payments records across 77,572 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Medtronic, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Kevin Foley
$16,505,077.51 across 45 reported transactions
- 2
Peter Ullrich
$4,804,699.00 across 4 reported transactions
- 3
Lawrence Lenke
$4,040,987.98 across 74 reported transactions
- 4
Christian Eversull
$2,760,011.00 across 2 reported transactions
- 5
Richard Hynes
$1,508,067.00 across 17 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Medtronic, Inc. ranks #16 of 1,925 by total payments (top 1% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,513 of 1,838 by HHI (bottom 18% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Ivoclar Vivadent, Inc. : $280.4K total payments, HHI 251
- MDD US Operations, LLC : $1.7M total payments, HHI 249
- Olympus Medical Systems Corporation : $242.8K total payments, HHI 248
- Verrica Pharmaceuticals Inc. : $1.1M total payments, HHI 248
- Recordati_rare_diseases_inc. : $714.2K total payments, HHI 247
- Prism Medical : $34.0K total payments, HHI 247
- Medtronic, Inc. (this company) : $117.7M total payments, HHI 247
- Coloplast Corp : $3.4M total payments, HHI 246
- Elevate Surgical CO : $14.4K total payments, HHI 244
- Alcon Vision LLC : $13.4M total payments, HHI 244
- kaleo, Inc. : $256.5K total payments, HHI 243
- Sandoz Inc. : $239.3K total payments, HHI 239
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Medtronic, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Medtronic, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Medtronic, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
BioNTech SE
$204.8M 179 recipients
Compare payment profiles
Boehringer Ingelheim Pharmaceuticals, Inc.
$148.9M 216,716 recipients
Compare payment profiles
Stryker Corporation
$141.0M 168,381 recipients
Compare payment profiles
GlaxoSmithKline, LLC.
$242.1M 341,439 recipients
Compare payment profiles
E.R. Squibb & Sons, L.L.C.
$251.5M 236,558 recipients
Compare payment profiles
Put this to use
Medtronic, Inc. ranks #16 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Medtronic, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Medtronic, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.